$LEVI

Peter E. Haas Jr. Family Fund sold $104K of LEVI

Peter E. Haas Jr. Family Fund sold 4,338 shares of LEVI STRAUSS & CO (LEVI) at $24.00 ($0.10M total) on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peter E. Haas Jr. Family Fund
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Neutral
high confidence
Mentioned
$LEVI
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVINeutralLow
01

Why it matters

The disclosed fact is the sale itself (4,338 shares for about $104.1k) and that it was executed under a pre-arranged 10b5-1 plan; no new business developments are provided.

02

Market read

Traders may note insider selling, but the 10b5-1 structure and small dollar amount relative to typical market moves suggest limited actionable signal.

03

What to watch

The article does not disclose whether other insiders or the company itself made offsetting purchases, so the net insider signal is incomplete.

Relevance 3/10Novelty 3/10Timing: filed 2026-05-28, sale dated 2026-05-27

Background

The article reports an SEC Form 4 insider transaction for LEVI by a 10% owner, Peter E. Haas Jr. Family Fund, including trade size, price, and post-sale holdings.

Company-level read

Ticker impact

$LEVINeutralHigh confidence
Context

LEVI is the issuer of a Form 4 showing Peter E. Haas Jr. Family Fund sold 4,338 shares at $24.0019 on 2026-05-27 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically muted for 10b5-1 sales.

Evidence & confidence

The filing is an open-market sale with a stated pre-arranged 10b5-1 plan and provides no new company-specific fundamentals beyond the transaction details.

Market effects

No sector-level signal; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • LEVI

    Levi Strauss & Co., the company whose shares were sold in the reported Form 4.

  • Peter E. Haas Jr. Family Fund

    10% owner reporting an open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVIHighAI 8/10

Levi's CEO admits the company missed the biggest jeans trend of the year

Levi Strauss & Co. (LEVI) CEO Michelle Gass admitted the company missed the U.S. shift to low-rise jeans during the back-to-school season, impacting its direct-to-consumer sales. Despite a 4% revenue increase to $1.6 billion in Q3, shares fell nearly 5%. Levi's has since refocused marketing on low-rise styles and expects full-year revenue growth of about 6%.

$LEVIMed

Levi Strauss CEO Sounds Alarm on Growing Competition in Denim Market

Levi Strauss reported mixed results: European revenue rose 4-5%, Asia saw 5-10% growth, and Signature brand revenue jumped 13%. The company raised its adjusted earnings forecast to $1.54-$1.56 per share but lowered its revenue growth outlook to ~7%. CEO Michelle Gass noted increased competition in the denim market, emphasizing the need for innovation to maintain market share.

$LEVIMed

BNP Paribas Exane raises Levi Strauss price target to $35

BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.